|
Status |
Public on Apr 13, 2024 |
Title |
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
To investigate transcriptomic changes regulated by DUSP6 in a HER2+ breast cancer cell line We performed gene expression profiling analysis using data obtained from RNA-seq of SCR vs DUSP6 KD MDA-MB-453 cells
|
|
|
Overall design |
Comparative gene expression profiling analysis of RNA-seq data for SCR controls vs. DUSP6 KD model
|
|
|
Contributor(s) |
Momeny M, Laajala T, Westermarck J |
Citation(s) |
38886591 |
|
Submission date |
May 02, 2023 |
Last update date |
Jul 13, 2024 |
Contact name |
Teemu Daniel Laajala |
E-mail(s) |
[email protected]
|
Organization name |
University of Turku
|
Department |
Department of Mathematics and Statistics
|
Street address |
Turun yliopisto
|
City |
Turku |
ZIP/Postal code |
20014 |
Country |
Finland |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (6)
|
GSM7287665 |
MDA-MB-453, Scrambled, Sample ID 1, rep1 |
GSM7287666 |
MDA-MB-453, Scrambled, Sample ID 2, rep2 |
GSM7287667 |
MDA-MB-453, Scrambled, Sample ID 4, rep3 |
GSM7287668 |
MDA-MB-453, DUSP6 Knockdown, Sample ID 3, rep1 |
GSM7287669 |
MDA-MB-453, DUSP6 Knockdown, Sample ID 5, rep2 |
GSM7287670 |
MDA-MB-453, DUSP6 Knockdown, Sample ID 6, rep3 |
|
This SubSeries is part of SuperSeries: |
GSE231526 |
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer |
|
Relations |
BioProject |
PRJNA966202 |